Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections

J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):351-353. doi: 10.1093/jpids/piy062.

Abstract

The epidemiology of Staphylococcus aureus infection in children is dynamic. We conducted a retrospective observational study on pediatric clinical cultures, performed between 2005 and 2017, that grew S aureus to determine temporal trends in antibiotic resistance. Although methicillin resistance declined, clindamycin and trimethoprim-sulfamethoxazole resistance increased significantly, especially among community-onset isolates.

Keywords: Staphylococcus aureus; antibiotic resistance; clindamycin; community-onset infection; pediatrics; trimethoprim-sulfamethoxazole.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Clindamycin / pharmacology*
  • Clindamycin / therapeutic use
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus
  • Retrospective Studies
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination